Faithward Advisors’s Pfizer PFE Stock Holding History

Faithward Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,434	Closed	-$209K	–	351
2026 Q1	$209K	Buy	+7,434	New	+$198K	0.03%	255
2025 Q4	–	Sell	-8,478	Closed	-$216K	–	336
2025 Q3	$216K	Buy	+8,478	New	+$209K	0.03%	290
2025 Q2	–	Sell	-12,314	Closed	-$312K	–	275
2025 Q1	$312K	Buy	12,314 +4,588	+59%	+$120K	0.05%	208
2024 Q4	$205K	Buy	+7,726	New	+$210K	0.03%	242
2022 Q3	–	Sell	-3,942	Closed	-$207K	–	264
2022 Q2	$207K	Buy	+3,942	New	+$201K	0.05%	140
2021 Q4	–	Sell	-5,658	Closed	-$243K	–	287
2021 Q3	$243K	Buy	+5,658	New	+$251K	0.05%	160

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Faithward Advisors's PFE Position: Q2 2026 in Review

Faithward Advisors sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,434 shares — an estimated $209K sold.

Faithward Advisors first reported a position in PFE in Q3 2021 and held it in 6 quarters. The position peaked at $312K in Q1 2025. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Faithward Advisors reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
Faithward Advisors sold 7,434 Pfizer shares in Q2 2026, an estimated $209K.
Faithward Advisors first reported a position in Pfizer in Q3 2021 and held it in 6 quarters.
Faithward Advisors's Pfizer position peaked at $312K in Q1 2025.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Faithward Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.